The HTT is enabled by the Pathfinder™ ACL System – a surgical instrument (Pathfinder™ ACL Guide) and a flexible, steerable guide wire (Pathfinder™ Guide Pin with Sheath). Typically, the HTT procedure places the ACL graft in the anatomical path equivalent to the native ACL and with equivalent tibial and femoral positioning.
The Pathfinder System was patented in the U.S. and international countries in 2014. FDA registration as a Class I surgical devices occurred in 2015. The first commercial patient use was in 2015. Since then, over 1,000 HTT procedures with the Pathfinder System have been performed with excellent clinical results. The Pathfinder is routinely used by multiple sports medicine surgeons in the U.S. and is being adopted rapidly in additional practices.
DanaMed’s corporate headquarters address is in Chadds Ford, PA – a Philadelphia suburb. Distribution, regulatory and quality assurance functions are located in Streetsboro, OH – a Cleveland suburb. Manufacturing is outsourced to parts manufacturers in five states.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.
